Vishwas Seshadri
CIK: 0001865131
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABEONA THERAPEUTICS INC.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 29, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct19.6K shares at avg. $5.16$101K - Jul 9, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct68K shares at avg. $6.96$473K - Jun 9, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct31.9K shares at avg. $5.30$169K - Jun 8, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct24.4K shares at avg. $5.43$133K - Jan 22, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct69.8K shares at avg. $5.33$372K - Jan 20, 2026ABEO
ABEONA THERAPEUTICS INC.
Award(A)Direct365.4K shares- - Dec 29, 2025ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct25K shares at avg. $5.31$133K - Oct 16, 2025ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct249 shares at avg. $5.49$1K - Sep 30, 2025ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct25K shares at avg. $5.24$131K - Sep 29, 2025ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct19.3K shares at avg. $5.39$104K - Jul 9, 2025ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct69.4K shares at avg. $5.86$407K - Jun 6, 2025ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct50.7K shares at avg. $6.76$343K - Jun 1, 2025ABEO
ABEONA THERAPEUTICS INC.
Tax Payment(F)Direct885 shares at avg. $6.24$6K - Mar 31, 2025ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct25K shares at avg. $4.78$120K - Jan 21, 2025ABEO
ABEONA THERAPEUTICS INC.
Award(A)Direct476.4K shares- - Oct 16, 2024ABEO
ABEONA THERAPEUTICS INC.
Tax Payment(F)Direct251 shares at avg. $6.54$2K - Sep 28, 2024ABEO
ABEONA THERAPEUTICS INC.
Tax Payment(F)Direct18.8K shares at avg. $5.89$111K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 29, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 19,608 | $5.16 | $101,091 | Direct |
| Jul 9, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 67,971 | $6.96 | $473,330 | Direct |
| Jun 9, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 31,916 | $5.30 | $169,289 | Direct |
| Jun 8, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 24,428 | $5.43 | $132,632 | Direct |
| Jan 22, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 69,832 | $5.33 | $372,267 | Direct |
| Jan 20, 2026 | ABEO ABEONA THERAPEUTICS INC. | Award(A) | 365,422 | - | $0 | Direct |
| Dec 29, 2025 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 25,000 | $5.31 | $132,740 | Direct |
| Oct 16, 2025 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 249 | $5.49 | $1,366 | Direct |
| Sep 30, 2025 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 25,000 | $5.24 | $130,930 | Direct |
| Sep 29, 2025 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 19,274 | $5.39 | $103,954 | Direct |
| Jul 9, 2025 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 69,420 | $5.86 | $406,503 | Direct |
| Jun 6, 2025 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 50,676 | $6.76 | $342,570 | Direct |
| Jun 1, 2025 | ABEO ABEONA THERAPEUTICS INC. | Tax Payment(F) | 885 | $6.24 | $5,522 | Direct |
| Mar 31, 2025 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 25,000 | $4.78 | $119,500 | Direct |
| Jan 21, 2025 | ABEO ABEONA THERAPEUTICS INC. | Award(A) | 476,435 | - | $0 | Direct |
| Oct 16, 2024 | ABEO ABEONA THERAPEUTICS INC. | Tax Payment(F) | 251 | $6.54 | $1,642 | Direct |
| Sep 28, 2024 | ABEO ABEONA THERAPEUTICS INC. | Tax Payment(F) | 18,798 | $5.89 | $110,720 | Direct |
1-17 of 17 transactions
About Seshadri Vishwas
Seshadri Vishwas (SEC CIK 0001865131) files insider reports with the SEC as Chief Executive Officer of ABEONA THERAPEUTICS INC. (ABEO).
Signal8 holds 15 ownership filings by Seshadri Vishwas, all Form 4s, filed between Sep 30, 2024 and Sep 29, 2026. Those filings report 17 transactions, from Sep 28, 2024 to Sep 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Seshadri Vishwas's filings is in CLEVELAND, OH.
Recent filings by Seshadri Vishwas
- Sep 29, 2026: Open-market sale of ABEO shares (Form 4, code S).
- Jul 9, 2026: Open-market sale of ABEO shares (Form 4, code S).
- Jun 9, 2026: Open-market sale of ABEO shares (Form 4, code S).
- Jun 8, 2026: Open-market sale of ABEO shares (Form 4, code S).
- Jan 22, 2026: Open-market sale of ABEO shares (Form 4, code S).
Other insiders filing for ABEONA THERAPEUTICS INC. (ABEO)
- Vazzano Joseph Walter, Chief Financial Officer
- O'Malley Brendan M., SVP, Chief Legal Officer
- Vasanthavada Madhav, Chief Commercial Officer
- Alvino Mark, Director
- Alland Leila, Director
- Silverstein Christine Berni, Director